The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Overview of Challenges and Opportunities in Revising the Nodal Classification of Lung Cancer.


Journal

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
ISSN: 1556-1380
Titre abrégé: J Thorac Oncol
Pays: United States
ID NLM: 101274235

Informations de publication

Date de publication:
04 2023
Historique:
received: 05 11 2022
revised: 12 12 2022
accepted: 16 12 2022
pmc-release: 01 04 2024
medline: 31 3 2023
pubmed: 27 12 2022
entrez: 26 12 2022
Statut: ppublish

Résumé

The status of lymph node involvement is a major component of the TNM staging system. The N categories for lung cancer have remained unchanged since the fourth edition of the TNM staging system, partly because of differences in nodal mapping nomenclature, partly because of insufficient details to verify possible alternative approaches for staging. In preparation for the rigorous analysis of the International Association for the Study of Lung Cancer database necessary for the ninth edition TNM staging system, members of the N-Descriptors Subcommittee of the International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee reviewed the evidence for alternative approaches to categorizing the extent of lymph node involvement with lung cancer, which is currently based solely on the anatomical location of lymph node metastasis. We reviewed the literature focusing on NSCLC to stimulate dialogue and mutual understanding among subcommittee members engaged in developing the ninth edition TNM staging system for lung cancer, which has been proposed for adoption by the American Joint Committee on Cancer and Union for International Cancer Control in 2024. The discussion of the range of possible revision options for the N categories, including the pros and cons of counting lymph nodes, lymph node stations, or lymph node zones, also provides transparency to the process, explaining why certain options may be discarded, others deferred for future consideration. Finally, we provide a preliminary discussion of the future directions that the N-Descriptors Subcommittee might consider for the 10th edition and beyond.

Identifiants

pubmed: 36572339
pii: S1556-0864(22)01985-2
doi: 10.1016/j.jtho.2022.12.009
pmc: PMC10065917
mid: NIHMS1860713
pii:
doi:

Types de publication

Journal Article Review Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

410-418

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA172253
Pays : United States

Informations de copyright

Copyright © 2022 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.

Références

Interact Cardiovasc Thorac Surg. 2020 Sep 1;31(3):305-314
pubmed: 32728705
J Thorac Oncol. 2021 Jun;16(6):897-901
pubmed: 33771657
JTO Clin Res Rep. 2021 Mar 09;2(4):100161
pubmed: 34590011
J Thorac Oncol. 2015 Nov;10(11):1515-22
pubmed: 26536193
J Thorac Oncol. 2007 Aug;2(8):686-93
pubmed: 17762334
Oncotarget. 2017 May 30;8(22):35700-35706
pubmed: 28415687
J Thorac Oncol. 2009 May;4(5):561-2
pubmed: 19395907
Ann Thorac Surg. 2012 May;93(5):1614-9; discussion 1619-20
pubmed: 22440365
Ann Thorac Surg. 2008 Nov;86(5):1626-30
pubmed: 19049761
J Thorac Oncol. 2008 Aug;3(8):880-6
pubmed: 18670306
Ann Thorac Surg. 2014 Mar;97(3):987-92
pubmed: 24480258
Transl Lung Cancer Res. 2016 Jun;5(3):258-64
pubmed: 27413707
Ann Thorac Surg. 2008 Jan;85(1):211-5
pubmed: 18154813
Adv Exp Med Biol. 2018;1116:27-36
pubmed: 29956198
Chest. 1986 Apr;89(4 Suppl):225S-233S
pubmed: 3514171
Lung Cancer. 2004 Feb;43(2):151-7
pubmed: 14739035
Ann Thorac Surg. 2016 Oct;102(4):1040-1
pubmed: 27645938
J Thorac Oncol. 2020 Mar;15(3):371-382
pubmed: 31783180
Ann Am Thorac Soc. 2017 Jul;14(7):1162-1168
pubmed: 28399376
J Thorac Oncol. 2007 Jul;2(7):603-12
pubmed: 17607115
J Thorac Oncol. 2022 Jun;17(6):806-815
pubmed: 35278692
Ann Thorac Surg. 2005 Jan;79(1):375-82
pubmed: 15620991
Chest. 1997 Jun;111(6):1718-23
pubmed: 9187199
J Thorac Cardiovasc Surg. 1978 Dec;76(6):832-9
pubmed: 713589
J Clin Oncol. 2003 Mar 15;21(6):1029-34
pubmed: 12637467
Chest. 2005 Sep;128(3):1545-50
pubmed: 16162756
Eur J Cardiothorac Surg. 2003 Dec;24(6):994-1001
pubmed: 14643819
J Thorac Oncol. 2009 May;4(5):568-77
pubmed: 19357537
Virchows Arch. 2018 Jun;472(6):939-947
pubmed: 29392400
Eur J Cardiothorac Surg. 1997 Aug;12(2):224-7
pubmed: 9288511
Ann Thorac Surg. 2005 Dec;80(6):2051-6; discussion 2056
pubmed: 16305843
Lancet Oncol. 2020 Nov;21(11):1413-1422
pubmed: 32979984
Cochrane Database Syst Rev. 2014 Nov 13;(11):CD009519
pubmed: 25393718
Ann Thorac Surg. 2014 Mar;97(3):957-64
pubmed: 24286635
JAMA Oncol. 2018 Jan 01;4(1):80-87
pubmed: 28973110
Chest. 2013 May;143(5 Suppl):e211S-e250S
pubmed: 23649440
J Thorac Oncol. 2012 Dec;7(12):1798-1806
pubmed: 23154551
Eur J Cardiothorac Surg. 2014 May;45(5):787-98
pubmed: 24578407
Chest. 1997 Jun;111(6):1710-7
pubmed: 9187198
Eur J Cardiothorac Surg. 2009 Sep;36(3):440-5
pubmed: 19464906
Medicina (Kaunas). 2021 Mar 23;57(3):
pubmed: 33807016
Ann Thorac Surg. 1999 Jun;67(6):1572-6
pubmed: 10391257
Thorac Cancer. 2022 Mar;13(5):708-715
pubmed: 35048499
Chest. 2010 Feb;137(2):436-42
pubmed: 20133290
Ann Thorac Surg. 2014 Feb;97(2):385-93
pubmed: 24266949
Ann Thorac Surg. 2002 Jan;73(1):245-8; discussion 248-9
pubmed: 11834017
J Thorac Oncol. 2020 Oct;15(10):1670-1681
pubmed: 32574595
J Thorac Oncol. 2006 Feb;1(2):120-5
pubmed: 17409840
J Thorac Oncol. 2007 Jul;2(7):583-4
pubmed: 17607110
J Thorac Oncol. 2011 Feb;6(2):310-8
pubmed: 21206387
Ann Thorac Surg. 2013 Oct;96(4):1178-1189
pubmed: 23910633
Chest. 2011 Aug;140(2):433-440
pubmed: 21292754
Eur J Cardiothorac Surg. 2019 Nov 1;56(5):849-857
pubmed: 31168596
J Thorac Oncol. 2020 Mar;15(3):344-359
pubmed: 31731014
Cancer. 2012 Sep 15;118(18):4512-8
pubmed: 22282325
N Engl J Med. 2022 May 26;386(21):1973-1985
pubmed: 35403841
Eur J Cardiothorac Surg. 2007 Feb;31(2):311-2
pubmed: 17187985
Lung Cancer. 2005 Jul;49(1):25-33
pubmed: 15949587
J Thorac Oncol. 2015 Dec;10(12):1675-84
pubmed: 26709477
Nat Rev Clin Oncol. 2019 Dec;16(12):763-771
pubmed: 31388125

Auteurs

Raymond Uyiosa Osarogiagbon (RU)

Multidisciplinary Thoracic Oncology Program, Baptist Cancer Center, Memphis, Tennessee. Electronic address: rosarogi@bmhcc.org.

Paul Van Schil (P)

Department of Thoracic and Vascular Surgery, Antwerp University Hospital, Antwerp University, Antwerp, Belgium.

Dorothy J Giroux (DJ)

Cancer Research and Biostatistics, Seattle, Washington.

Eric Lim (E)

Imperial College London, London, United Kingdom; The Academic Division of Thoracic Surgery, Royal Brompton Hospital, London, United Kingdom.

Paul Martin Putora (PM)

Department of Radiation Oncology, Kantonsspital St. Gallen, St. Gallen, Switzerland; Department of Radiation Oncology, University of Bern, Bern, Switzerland.

Yolande Lievens (Y)

Radiation Oncology Department, Ghent University Hospital, Ghent, Belgium.

Giuseppe Cardillo (G)

Azienda Ospedaliera San Camillo-Forlanini, Rome, Italy; UniCamillus-Saint Camillus International University of Health Sciences, Rome, Italy.

Hong Kwan Kim (HK)

Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Gaetano Rocco (G)

Thoracic Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.

Andrea Bille (A)

Department of Thoracic Surgery, Guy's Hospital, London, United Kingdom; King's College University, London, United Kingdom.

Helmut Prosch (H)

Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna General Hospital, Vienna, Austria.

Francisco Suárez Vásquez (FS)

Thoracic Surgeon, Surgery Department, Clínica Santa María, Santiago, Chile; Universidad de Los Andes, Santiago, Chile.

Katherine K Nishimura (KK)

Cancer Research and Biostatistics, Seattle, Washington.

Frank Detterbeck (F)

Department of Surgery, Yale University, New Haven, Connecticut.

Ramon Rami-Porta (R)

Department of Thoracic Surgery, Hospital Universitari Mútua Terrassa, University of Barcelona, Terrassa, Barcelona, Spain; Network of Centres for Biomedical Research in Respiratory Diseases (CIBERES) Lung Cancer Group, Terrassa, Barcelona, Spain.

Valerie W Rusch (VW)

Thoracic Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.

Hisao Asamura (H)

Division of Thoracic Surgery, Keio University School of Medicine, Tokyo, Japan.

James Huang (J)

Thoracic Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH